Given that the pro-apoptotic activity of miR-92a depends on the presence of an intact p53 pathway, it is important to consider the effects of expressing this microRNA when p53 is absent, as is the case in a large fraction of human tumours. The gene discussed is TP53; the disease is neoplasm.